article_metadata: Lanzi Ou Yicong Tang Yanming Deng Lijie Guo Qingqing He Tingting He Weineng Feng
article_metadata: 10.3389/fonc.2022.911362
article_metadata: Front Oncol
article_metadata: 2022 Jul 26;12:911362.
article_metadata: cux1-met fusion egfr mutations icotinib plus crizotinib lung adenocarcinoma partial response
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/35957915/
article_metadata: Case Reports
article_metadata: PMC9360523
article_metadata: 35957915
article_metadata: Case Report: Durable partial response to icotinib plus crizotinib in a lung adenocarcinoma patient with double uncommon EGFR G719D/L861Q mutations and an acquired novel CUX1- MET fusion
article_metadata: 2022